ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Business

Cipla sells Chase Pharma stake to Allergan

MUMBAI (NewsRise) - Cipla's U.K. unit has sold its stake in Chase Pharmaceuticals, a U.S.-based company developing a drug to treat Alzheimer's disease, to Allergan.

Cipla (EU) held a 16.7% stake in Chase via a syndicated venture investment. In 2014, Mumbai-based Cipla invested $1.5 million to snap up a 14.6% stake in Chase through the syndicate to finance the initial phases of clinical trials for the company's drug CPC 201 to treat Alzheimer's disease.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more